Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-19
1990-07-24
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544143, 544373, 548495, 5142332, 514253, C07D20928, C07D41302, C07D40302, A61K 31405
Patent
active
049435876
ABSTRACT:
The present invention is novel selected hydroxamic acid derivatives of acyl residues of selected NSAIDS, i.e. having 5-lipoxygenase and cyclooxygenase inhibiting properties, pharmaceutical compositions for treating conditions advantageously affected by the inhibition and methods for treating these conditions in mammals, including humans suffering therefor.
REFERENCES:
patent: 3624103 (1971-11-01), DeMartillis
patent: 4029815 (1977-06-01), Sherlock
patent: 4092430 (1978-05-01), Sallmann et al.
patent: 4173577 (1979-11-01), Sallmann et al.
Poster Session--ACS Meeting New Orleans 9/87.
J. Med. Chem., 1987, 30, 574-580.
J. Med. Chem., 1987, 30, 2121-2126.
Wolf, E., and Kohl, H. Ann. Chem. Liegigs, 1975, 1245-1251.
Cetenko Wiaczeslaw A.
Connor David T.
Flynn Daniel L.
Sircar Jagadish C.
Springer David B.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Hydroxamate derivatives of selected nonsteroidal antiinflammator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamate derivatives of selected nonsteroidal antiinflammator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamate derivatives of selected nonsteroidal antiinflammator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1268063